View an enhanced version of our Annual Report.
View an enhanced version of our Proxy Statement.
Your vote is IMPORTANT!
Please vote your proxy online now or by phone by dialing 866-859-2528.
Date:
June 12, 2025
Time:
1:00 PM PT
Location:
465 North Halstead Street
Suite 200
Pasadena, California 91107
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and multiple XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein’s structure that result in new mechanisms of therapeutic action.
